COMPANY

Concept Medical

HQ: Tampa, FL source · conceptmedical.com ↗

FDA-cleared device company Clinical Phase 3

Location: Tampa, FL · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Arterial Disease of Legs Coronary Artery Disease Peripheral Artery Disease Atherosclerosis Cardiovascular Diseases Popliteal Artery Disease Superficial Femoral Artery Disease Below-the-knee Obstruction PAD - Peripheral Arterial Disease Native Coronary Artery Stenosis Arterial Disease In-Stent Restenosis Diabetes Acute Coronary Syndrome MagicTouch PTA Sirolimus drug coated balloon Xtreme Touch - Neo sirolimus coated PTA balloon catheter

9Trials (company is sponsor)

Funding and NIH signals

SEC Form D raise Form D reports $60.04M sold since 2018 (filed Apr 24, 2026); +2 other Form D filings in the last 12 months. SEC Form D 0002108675-26-000003 (Apr 24, 2026)
Evidence (3 events)
- Apr 24, 2026 · SEC Form D 0002108675-26-000003
  Name of Issuer: Concept Medical, Inc.; CIK: 2108675; Address: Tampa, FL; Submission type: D; Filing date: 2026-04-24; Industry Group: Other Health Care; Date of First Sale: 2018-08-15; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: 65000000; Total Amount Sold: 60037410; Federal exemptions: 06b
- Apr 24, 2026 · SEC Form D 0002108675-26-000001
  Name of Issuer: Concept Medical, Inc.; CIK: 2108675; Address: Tampa, FL; Submission type: D; Filing date: 2026-04-24; Industry Group: Other Health Care; Date of First Sale: 2011-08-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 600000; Total Amount Sold: 600000; Federal exemptions: 06b
- Apr 24, 2026 · SEC Form D 0002108675-26-000002
  Name of Issuer: Concept Medical, Inc.; CIK: 2108675; Address: Tampa, FL; Submission type: D; Filing date: 2026-04-24; Industry Group: Other Health Care; Date of First Sale: 2017-05-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 75000; Total Amount Sold: 75000; Federal exemptions: 04

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

2026-04 Trial start Phase 2/Phase 3: A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. source ↗
May 20, 2025 Trial start Not phased (device or behavioral study): MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels source ↗
Jan 16, 2025 Trial start Not phased (device or behavioral study): Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease source ↗
Apr 16, 2024 Trial start Not phased (device or behavioral study): MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions source ↗
Sep 8, 2020 Trial start Not phased (device or behavioral study): Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease source ↗
Aug 20, 2020 Trial start Not phased (device or behavioral study): ABLUMINUS DES BTK Registry - FIM source ↗
Aug 15, 2020 Trial start Not phased (device or behavioral study): SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease source ↗
Jun 15, 2020 Trial start Not phased (device or behavioral study): Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global source ↗
Nov 21, 2018 Trial start —: Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease source ↗

Upcoming milestones

2026-12 (ESTIMATED) · Not phased · SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease · NCT04511247
Dec 1, 2026 (ESTIMATED) · Not phased · Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease · NCT06182397
2027-12 (ESTIMATED) · Phase 2/Phase 3 · A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. · NCT07359807
2028-11 (ESTIMATED) · Not phased · MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels · NCT06271590

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 9

Record	Title	Phase	Status	Start	Primary completion
NCT07359807	A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.	Phase 2/Phase 3	Not yet recruiting	2026-04	2027-12 (estimated)
NCT06182397	Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease	Not phased (device or behavioral study)	Recruiting	Jan 16, 2025	Dec 1, 2026 (estimated)
NCT06271590	MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels	Not phased (device or behavioral study)	Recruiting	May 20, 2025	2028-11 (estimated)
NCT04511234	Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease	Not phased (device or behavioral study)	Recruiting	Sep 8, 2020	2025-12 (estimated)
NCT04511247	SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease	Not phased (device or behavioral study)	Recruiting	Aug 15, 2020	2026-12 (estimated)
NCT05908331	MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions	Not phased (device or behavioral study)	Recruiting	Apr 16, 2024	2025-09 (estimated)
NCT04562740	ABLUMINUS DES BTK Registry - FIM	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	Aug 20, 2020	Jun 1, 2024 (estimated)
NCT04236609	Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	Jun 15, 2020	Oct 30, 2023 (estimated)
NCT04368091	Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease	Not listed	Completed	Nov 21, 2018	Apr 25, 2020 (actual)